Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Baxter
Merck
Teva
US Army
Federal Trade Commission

Generated: September 16, 2019

DrugPatentWatch Database Preview

Patent: 8,975,382

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,975,382
Title:Amino acid sequences directed against HER2 and polypeptides comprising the same for the treatment of cancers and/or tumors
Abstract: The present invention relates to amino acid sequences and Nanobodies that are directed against Epidermal Growth Factor Receptor 2 (HER2), as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such amino acid sequences.
Inventor(s): Revets; Hilde Adi Pierrette (Meise, BE), Boutton; Carlo (Wielsbeke, BE), Hoogenboom; Hendricus Renerus Jacobus Mattheus (Maastricht, NL)
Assignee: Ablynx N.V. (Zwijnaarde, BE)
Application Number:12/744,991
Patent Claims:see list of patent claims

Details for Patent 8,975,382

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25   Try a Free Trial Ablynx N.V. (Zwijnaarde, BE) 2027-11-27 RX Orphan search
Genentech PERJETA pertuzumab VIAL; SINGLE-USE 125409 001 2012-06-08   Try a Free Trial Ablynx N.V. (Zwijnaarde, BE) 2027-11-27 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
McKinsey
Chinese Patent Office
Federal Trade Commission
Fuji
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.